• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDEAVOR RESOLUTE RX; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDEAVOR RESOLUTE RX; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Catalog Number ERES27518X
Device Problem Material Distortion (2977)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 06/29/2014
Event Type  malfunction  
Event Description
The physician was attempting to treat a lesion in the lad with an endeavor resolute drug eluting stent.The device was inspected prior to use with no issues noted.The lesion exhibited 75% stenosis, calcification and tortuosity.The lesion was pre-dilated; however the endeavor resolute stent could not pass the lesion.The physician used a new device to complete the surgery.The patient is good.No damage to the stent was reported, however, following evaluation of the returned device stent deformation was confirmed.Evaluation summary : the stent had moved distally on the balloon.The 1st distal stent segment was covering the distal marker band.Crimp impressions were evident on the exposed balloon portion.The 5th to 8th distal stent segments were raised and deformed.Please note that this device (endeavor resolute) is distributed outside the united states; however, it is similar to the united states distributed product (resolute integrity).
 
Manufacturer Narrative
Evaluation results: inherent risk of procedure (stent deformation).Patient condition affected effectiveness of the device (target lesion exhibited 75% stenosis, calcification and tortuosity).Deformation problem.Evaluation conclusion: known inherent risk of procedure (stent deformation).Device failure/lack of effectiveness related to patient condition device (target lesion exhibited 75% stenosis, calcification and tortuosity).(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDEAVOR RESOLUTE RX
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key4039895
MDR Text Key4864448
Report Number9612164-2014-01140
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
P110013
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 08/20/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/27/2014
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/21/2015
Device Catalogue NumberERES27518X
Device Lot Number0006629246
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/05/2014
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/20/2014
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/21/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age00069 YR
-
-